Spectinamides as anti-tuberculosis agents
US9284325B2 · kind B2 · utility
0Cited by
3References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2014 |
| Grant date | Mar 15, 2016 |
| Priority date | — |
| Expiry date | Mar 23, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel 3′-deoxy-3′-acylaminospectinomycin compounds are described. Also described are methods of using the 3′-deoxy-3-acylaminospectinomycin compounds and other spectinomycin analogs in treating tuberculosis and in treating microbial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.